unilateral and bilateral ovarian endometriomas
Conditions
Interventions
Two groups:Application of gelantine-thrombin matrix sealant (FloSeal) for haemostasis after the stripping of endometriomas. Application of gelantine-thrombin matrix sealant (FloSeal) for haemostasis a
Sponsors
Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Patient with clinical and ultrasound diagnosis of unilateral ovarian endometriomas. Aged between 18 and 40 years with regular menstrual cycles (21-35 days) at the time of operation.
Exclusion criteria
Exclusion criteria: Patient with polycystic ovarian syndrome according to the Rotterdam criteria 20, pregnancy, active pelvic inflammatory disease, genital or extragenital malignancy, intraoperative diagnosis of another cyst type, conversion to laparotomy, use of GnRH or COC therapy in the follow–up period, and irregular attendance of follow-up examinations. Refuse or incompetence for informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pre- and postoperative hormonal profiles including, AMH, FSH, LH, testosterone and estradiol.;Ultrasound findings such as antral follicle count, ovarian stromal blood flow, ovarian volume; | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) The operative finding - the estimated blood loss and operative duration are recorded.;2) Assessment of patient satisfaction - Patient attitude towards the treatment will be assessed by an 8-item client satisfaction questionnaire (CSQ-8).;3) Experience of any complications.; | — |
Countries
China
Contacts
Public ContactDr. CHUNG Pui Wah, Jacqueline
Department of Obstetrics & Gynaecology, Prince of Wales Hospital
Outcome results
None listed